Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide is a synthetic nine-amino acid tag (sequence: YPYDVPDYA) that enables precise detection and purification of HA-tagged proteins via competitive binding to anti-HA antibodies (A6004 product page). Its high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) supports diverse biochemical workflows. The HA tag is validated for quantitative immunoprecipitation and elution of fusion proteins, improving experimental reproducibility (Dong et al., 2025). High purity (>98%) and sequence specificity minimize cross-reactivity and background. This article synthesizes peer-reviewed evidence and product benchmarks to clarify HA tag applications and limitations for protein interaction research.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from the human influenza virus hemagglutinin protein, serving as a universal epitope tag in molecular biology (Epitopeptide.com). The nine-residue sequence (YPYDVPDYA) is recognized with high affinity by commercial anti-HA antibodies. This tag enables detection, purification, and elution of HA-tagged fusion proteins in heterogeneous samples. The HA tag is inert and does not significantly affect the function or localization of fused proteins under standard conditions (A6004 kit). By providing a standardized molecular handle, the HA peptide accelerates reproducible research in fields such as cancer biology, ubiquitin signaling, and protein-protein interaction analysis (LabPe.com—this article extends mechanistic insight with quantitative benchmarks).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions by presenting a specific linear epitope that is selectively bound by anti-HA antibodies. In immunoprecipitation workflows, proteins fused to the HA tag are captured on anti-HA magnetic beads or resin. The addition of excess free HA peptide competitively displaces the HA-tagged protein, enabling its gentle elution for downstream analysis. This mechanism enables highly specific, non-denaturing elution, preserving protein complexes and post-translational modifications. The peptide shows high solubility across solvents (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water, measured at 25°C and neutral pH), facilitating its integration into multiple experimental buffers (A6004 kit).

Evidence & Benchmarks

• HA tag (YPYDVPDYA) enables quantitative recovery of fusion proteins from anti-HA antibody matrices in immunoprecipitation assays (Dong et al., 2025).
• High-purity synthetic HA peptide (>98%, validated by HPLC and MS) reduces non-specific elution and background in complex lysates (A6004 kit).
• Competitive elution with HA peptide preserves native protein-protein interactions and post-translational modifications (Anti-inflammatory-peptide-1.com—this article details biochemical advantages; here we add cross-study benchmarks).
• The HA tag is compatible with both conventional (monoclonal/polyclonal) anti-HA antibodies and magnetic bead-based capture platforms (Vatalis.com).
• HA peptide does not cross-react with common mammalian proteins, minimizing off-target background in immunoblotting and mass spectrometry (Influenza-hemagglutinin-ha-peptide.com—we update with new purity and performance metrics).

Applications, Limits & Misconceptions

Applications:

• Elution of HA-tagged fusion proteins from anti-HA matrices in immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) workflows.
• Detection of HA-tagged constructs by Western blot, ELISA, and immunofluorescence.
• Affinity purification of low-abundance or labile protein complexes.
• Quantitative analysis of ubiquitination, post-translational modifications, and protein-protein interactions (Dong et al., 2025).

Common Pitfalls or Misconceptions

• HA peptide does not elute non-HA-tagged proteins; its efficacy is limited to proteins containing the exact YPYDVPDYA epitope.
• Long-term storage of peptide solutions is discouraged; stability is optimal when stored desiccated at -20°C (A6004 kit).
• Very high concentrations of HA peptide may inhibit antibody binding in downstream detection if not removed by buffer exchange.
• Epitope tagging may occasionally alter the function or localization of sensitive target proteins—empirical validation is recommended.
• HA tag is not a substitute for structural or functional domain mapping; it is an affinity handle, not a reporter or folding motif.

Workflow Integration & Parameters

The HA peptide is compatible with a wide range of lysis buffers and experimental conditions. For immunoprecipitation, typical workflows involve binding HA-tagged proteins to anti-HA antibody beads, washing, and eluting with 1–2 mg/mL synthetic HA peptide in neutral buffer (e.g., PBS or TBS, pH 7.4) at 4–25°C. Elution efficiency is maximized by incubating for 10–30 minutes with gentle agitation. Downstream applications include Western blot, mass spectrometry, and functional assays. For optimal performance, use freshly prepared peptide solutions and avoid repeated freeze/thaw cycles. Product A6004 is supplied at >98% purity to minimize artifacts. For advanced workflow design and troubleshooting, see Redefining Precision in Protein Interaction Research (this article delivers new quantitative solubility and purity parameters), and Unlocking Precision in Protein-Protein Interaction Studies (we extend with updated evidence on ubiquitin signaling applications).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide provides a robust, high-specificity platform for the detection and purification of HA-tagged fusion proteins. Its defined sequence, high solubility, and purity enable reproducible, quantitative workflows in protein interaction and ubiquitination research. Proper use of the HA peptide as an epitope tag improves signal-to-noise, preserves protein complexes, and supports advanced analyses such as post-translational modification mapping. Ongoing studies, such as Dong et al. (2025), underscore the peptide's utility in dissecting complex signaling pathways, including ubiquitin-mediated regulation of metastasis. As experimental demands increase, the HA tag remains a cornerstone for next-generation molecular biology workflows (Influenza Hemagglutinin (HA) Peptide, A6004).